Explore News
-
Colon Cancer Breakthrough Keeps Patients Cancer-Free for Nearly 3 Years
A pioneering UK-led trial shows that brief pre-surgery immunotherapy with pembrolizumab leads to long-term remission…
A pioneering UK-led trial shows that brief pre-surgery immunotherapy with pembrolizumab leads to long-term remission…
